[PHARMA] YoY TTM Result on 30-Jun-2010 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
11-Aug-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
30-Jun-2010 [#2]
Profit Trend
QoQ- -5.37%
YoY- -14.14%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Revenue 1,846,836 1,642,700 1,492,216 1,321,763 1,289,459 1,290,632 1,112,447 8.80%
PBT 79,270 102,587 53,876 69,675 86,658 103,949 32,429 16.04%
Tax -29,878 -34,308 -17,749 -17,335 -24,472 -33,502 -16,635 10.24%
NP 49,392 68,279 36,127 52,340 62,186 70,447 15,794 20.90%
-
NP to SH 47,949 67,151 35,734 52,027 60,598 69,023 14,068 22.65%
-
Tax Rate 37.69% 33.44% 32.94% 24.88% 28.24% 32.23% 51.30% -
Total Cost 1,797,444 1,574,421 1,456,089 1,269,423 1,227,273 1,220,185 1,096,653 8.57%
-
Net Worth 480,568 481,394 451,517 417,065 400,161 362,716 314,357 7.32%
Dividend
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Div 41,172 52,948 - 118,755 57,770 38,516 16,038 16.99%
Div Payout % 85.87% 78.85% - 228.26% 95.33% 55.80% 114.01% -
Equity
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Net Worth 480,568 481,394 451,517 417,065 400,161 362,716 314,357 7.32%
NOSH 258,370 117,700 106,994 106,939 106,995 106,995 106,924 15.82%
Ratio Analysis
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
NP Margin 2.67% 4.16% 2.42% 3.96% 4.82% 5.46% 1.42% -
ROE 9.98% 13.95% 7.91% 12.47% 15.14% 19.03% 4.48% -
Per Share
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
RPS 714.80 1,395.66 1,394.66 1,235.99 1,205.16 1,206.24 1,040.41 -6.05%
EPS 18.56 57.05 33.40 48.65 56.64 64.51 13.16 5.89%
DPS 15.94 44.99 0.00 111.00 54.00 36.00 15.00 1.01%
NAPS 1.86 4.09 4.22 3.90 3.74 3.39 2.94 -7.34%
Adjusted Per Share Value based on latest NOSH - 106,939
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
RPS 128.14 113.98 103.54 91.71 89.47 89.55 77.19 8.80%
EPS 3.33 4.66 2.48 3.61 4.20 4.79 0.98 22.59%
DPS 2.86 3.67 0.00 8.24 4.01 2.67 1.11 17.06%
NAPS 0.3334 0.334 0.3133 0.2894 0.2777 0.2517 0.2181 7.32%
Price Multiplier on Financial Quarter End Date
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Date 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 30/06/08 29/06/07 -
Price 4.49 10.18 5.90 4.98 3.80 3.27 3.53 -
P/RPS 0.63 0.73 0.42 0.40 0.32 0.27 0.34 10.81%
P/EPS 24.19 17.84 17.67 10.24 6.71 5.07 26.83 -1.70%
EY 4.13 5.60 5.66 9.77 14.90 19.73 3.73 1.71%
DY 3.55 4.42 0.00 22.29 14.21 11.01 4.25 -2.95%
P/NAPS 2.41 2.49 1.40 1.28 1.02 0.96 1.20 12.31%
Price Multiplier on Announcement Date
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Date 16/08/13 08/08/12 10/08/11 11/08/10 21/08/09 14/08/08 17/08/07 -
Price 4.66 8.83 5.90 4.95 4.00 3.44 3.44 -
P/RPS 0.65 0.63 0.42 0.40 0.33 0.29 0.33 11.94%
P/EPS 25.11 15.48 17.67 10.17 7.06 5.33 26.15 -0.67%
EY 3.98 6.46 5.66 9.83 14.16 18.75 3.82 0.68%
DY 3.42 5.09 0.00 22.42 13.50 10.47 4.36 -3.96%
P/NAPS 2.51 2.16 1.40 1.27 1.07 1.01 1.17 13.55%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment